EU regulators see info from rivals, customers in Catalent's sale to Novo Holdings
European Union antitrust officials are asking rival pharmaceuticals firms for their input on Novo Holdings planned $16.5 ...
Yahoo Finance13h
JAZZ or CTLT: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Drugs stocks are likely familiar with Jazz Pharmaceuticals (JAZZ) and Catalent (CTLT). But which of these two stocks is more attractive to value investors? We'll need ...
Hosted on MSN16d
What to Expect From Catalent's Next Quarterly Earnings Report
Catalent, Inc. (CTLT), headquartered in Somerset, New Jersey, is a significant provider in the pharmaceutical and biotech ...
Zacks.com on MSN7d
Catalent's Stock Gains Despite Q1 Earnings Miss, Gross Margin Up
CTLT's solid segmental results led to an encouraging fiscal first-quarter performance, driving share prices in after-hours ...
Catalent (NYSE:CTLT) Downgraded by StockNews.com to “Sell”
Catalent (NYSE:CTLT – Get Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a report ...
Catalent’s Biologics Underperformance and PCH Stability Lead to Hold Rating
Jefferies analyst David Windley maintained a Hold rating on Catalent (CTLT – Research Report) today and set a price target of $63.50.
EU regulators see info from rivals, customers in Catalent sale to Novo Holdings - Reuters
European Union seeks input from rival pharmaceutical firms on Novo Holdings' $16.5 billion acquisition of Catalent.
Seeking Alpha11h
EU regulators seek info from rivals, customers in Catalent sale to Novo Holdings - Reuters
European Union antitrust officials are asking rival pharmaceuticals firms for their input on Novo Holdings planned $16.5 ...